Literature DB >> 11385344

Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background.

J M Hickner1, J G Bartlett, R E Besser, R Gonzales, J R Hoffman, M A Sande.   

Abstract

The following principles of appropriate antibiotic use for adults with acute rhinosinusitis apply to the diagnosis and treatment of acute maxillary and ethmoid rhinosinusitis in adults who are not immunocompromised. Most cases of acute rhinosinusitis diagnosed in ambulatory care are caused by uncomplicated viral upper respiratory tract infections. Bacterial and viral rhinosinusitis are difficult to differentiate on clinical grounds. The clinical diagnosis of acute bacterial rhinosinusitis should be reserved for patients with rhinosinusitis symptoms lasting 7 days or more who have maxillary pain or tenderness in the face or teeth (especially when unilateral) and purulent nasal secretions. Patients with rhinosinusitis symptoms that last less than 7 days are unlikely to have bacterial infection, although rarely some patients with acute bacterial rhinosinusitis present with dramatic symptoms of severe unilateral maxillary pain, swelling, and fever. Sinus radiography is not recommended for diagnosis in routine cases. Acute rhinosinusitis resolves without antibiotic treatment in most cases. Symptomatic treatment and reassurance is the preferred initial management strategy for patients with mild symptoms. Antibiotic therapy should be reserved for patients with moderately severe symptoms who meet the criteria for the clinical diagnosis of acute bacterial rhinosinusitis and for those with severe rhinosinusitis symptoms-especially those with unilateral facial pain-regardless of duration of illness. For initial treatment, the most narrow-spectrum agent active against the likely pathogens, Streptococcus pneumoniae and Haemophilus influenzae, should be used.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11385344     DOI: 10.1067/s0196-0644(01)70089-3

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  6 in total

1.  Canadian clinical practice guidelines for acute and chronic rhinosinusitis.

Authors:  Martin Desrosiers; Gerald A Evans; Paul K Keith; Erin D Wright; Alan Kaplan; Jacques Bouchard; Anthony Ciavarella; Patrick W Doyle; Amin R Javer; Eric S Leith; Atreyi Mukherji; R Robert Schellenberg; Peter Small; Ian J Witterick
Journal:  Allergy Asthma Clin Immunol       Date:  2011-02-10       Impact factor: 3.406

Review 2.  Acute rhinosinusitis : a pharmacoeconomic review of antibacterial use.

Authors:  Jean-Blaise Wasserfallen; Françoise Livio; Giorgio Zanetti
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

3.  Antibiotic prescribing in patients with acute rhinosinusitis is not in agreement with European recommendations.

Authors:  Lars Christian Jørgensen; Sarah Friis Christensen; Gloria Cordoba Currea; Carl Llor; Lars Bjerrum
Journal:  Scand J Prim Health Care       Date:  2013-06       Impact factor: 2.581

4.  Use of behavioral economics and social psychology to improve treatment of acute respiratory infections (BEARI): rationale and design of a cluster randomized controlled trial [1RC4AG039115-01]--study protocol and baseline practice and provider characteristics.

Authors:  Stephen D Persell; Mark W Friedberg; Daniella Meeker; Jeffrey A Linder; Craig R Fox; Noah J Goldstein; Parth D Shah; Tara K Knight; Jason N Doctor
Journal:  BMC Infect Dis       Date:  2013-06-27       Impact factor: 3.090

5.  A comparison of the efficacy of amoxicillin and nasal irrigation in treatment of acute sinusitis in children.

Authors:  Abolfazl Khoshdel; Gholam Reza Panahande; Mohamad Kazem Noorbakhsh; Mohamad Reza Malek Ahmadi; Masoud Lotfizadeh; Neda Parvin
Journal:  Korean J Pediatr       Date:  2014-11-30

Review 6.  Fever and the rational use of antimicrobials in the emergency department.

Authors:  Raquel F Harrison; Helen Ouyang
Journal:  Emerg Med Clin North Am       Date:  2013-09-12       Impact factor: 2.264

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.